Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Sep;35(9):1092-9.
doi: 10.1086/677624. Epub 2014 Jul 23.

Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship

Jimish M Mehta  1 , Kevin Haynes, E Paul Wileyto, Jeffrey S Gerber, Daniel R Timko, Steven C Morgan, Shawn Binkley, Neil O Fishman, Ebbing Lautenbach, Theoklis Zaoutis; Centers for Disease Control and Prevention Epicenter Program
Affiliations
Clinical Trial

Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship

Jimish M Mehta et al. Infect Control Hosp Epidemiol. 2014 Sep.

Abstract

Objective: Although prior authorization and prospective audit with feedback are both effective antimicrobial stewardship program (ASP) strategies, the relative impact of these approaches remains unclear. We compared these core ASP strategies at an academic medical center.

Design: Quasi-experimental study.

Methods: We compared antimicrobial use during the 24 months before and after implementation of an ASP strategy change. The ASP used prior authorization alone during the preintervention period, June 2007 through May 2009. In June 2009, many antimicrobials were unrestricted and prospective audit was implemented for cefepime, piperacillin/tazobactam, and vancomycin, marking the start of the postintervention period, July 2009 through June 2011. All adult inpatients who received more than or equal to 1 dose of an antimicrobial were included. The primary end point was antimicrobial consumption in days of therapy per 1,000 patient-days (DOT/1,000-PD). Secondary end points included length of stay (LOS).

Results: In total, 55,336 patients were included (29,660 preintervention and 25,676 postintervention). During the preintervention period, both total systemic antimicrobial use (-9.75 DOT/1,000-PD per month) and broad-spectrum anti-gram-negative antimicrobial use (-4.00 DOT/1,000-PD) declined. After the introduction of prospective audit with feedback, however, both total antimicrobial use (+9.65 DOT/1,000-PD per month; P < .001) and broad-spectrum anti-gram-negative antimicrobial use (+4.80 DOT/1,000-PD per month; P < .001) increased significantly. Use of cefepime and piperacillin/tazobactam both significantly increased after the intervention (P = .03). Hospital LOS and LOS after first antimicrobial dose also significantly increased after the intervention (P = .016 and .004, respectively).

Conclusions: Significant increases in antimicrobial consumption and LOS were observed after the change in ASP strategy.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. All other authors report no conflicts of interest relevant to this article. All authors submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest, and the conflicts that the editors consider relevant to this article are disclosed here.

Figures

FIGURE 1
FIGURE 1
Timeline of antimicrobial stewardship program (ASP) strategies for broad-spectrum antimicrobials at the Hospital of the University of Pennsylvania.
FIGURE 2
FIGURE 2
Trends in consumption of broad-spectrum anti-gram-negative agents (days of therapy per 1,000 patient-days) by month for the 4-year study period.
FIGURE 3
FIGURE 3
Trends in consumption for all systemic antimicrobials, nonaudited antimicrobials, vancomycin, and antifungal agents (days of therapy per 1,000 patient-days) by month for the 4-year study period.
FIGURE 4
FIGURE 4
Trends in length of stay for total hospitalization and in length of stay after receipt of antimicrobials by month for the 4-year study period.
See this image and copyright information in PMC

Comment in

References

    1. Fishman N. Antimicrobial stewardship. Am J Med. 2006;119(6) suppl 1:S53–S61. - PubMed
    1. Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–177. - PubMed
    1. Drew RH, White R, MacDougall C, Hermsen ED, Owens RC Society of Infectious Diseases Pharmacists. Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy. 2009;29(5):593–607. - PubMed
    1. Fraser GL, Stogsdill P, Dickens JD, Wennberg DE, Smith RP, Prato BS. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med. 1997;157(15):1689–1694. - PubMed
    1. Solomon DH, Van Houten L, Glynn RJ, et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med. 2001;161(15):1897–1902. - PubMed

Publication types

MeSH terms

Substances